Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease
在慢性肾脏病4期或5期患者中,替格瑞洛比氯吡格雷更能抑制血小板聚集并减轻炎症负担。
期刊:Vascular Pharmacology
影响因子:3.5
doi:10.1016/j.vph.2023.107143
Jain, Nishank; Corken, Adam; Arthur, John M; Ware, Jerry; Arulprakash, Narenraj; Dai, Junqiang; Phadnis, Milind A; Davis, Otis; Rahmatallah, Yasir; Mehta, J L; Hedayati, S Susan; Smyth, Susan